3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Valeritas Holdings's 3-Year ROIIC % for the quarter that ended in Dec. 2018 was 0.00%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Valeritas Holdings's 3-Year ROIIC % or its related term are showing as below:
VLRXQ's 3-Year ROIIC % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -1.98 * Ranked among companies with meaningful 3-Year ROIIC % only.
Valeritas Holdings 3-Year ROIIC % Historical Data
The historical data trend for Valeritas Holdings's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Valeritas Holdings's 3-Year ROIIC %
For the Medical Instruments & Supplies subindustry, Valeritas Holdings's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Valeritas Holdings's 3-Year ROIIC % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Valeritas Holdings's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Valeritas Holdings's 3-Year ROIIC % falls into.
Valeritas Holdings 3-Year ROIIC % Calculation
Valeritas Holdings's 3-Year ROIIC % for the quarter that ended in Dec. 2018 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -42.09 (Dec. 2018) - -47.343 (Dec. 2015) )
/
( 11.95 (Dec. 2018) - 86.33 (Dec. 2015) )
=
5.253
/
-74.38
=
-7.06%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Valeritas Holdings 3-Year ROIIC % Related Terms
Thank you for viewing the detailed overview of Valeritas Holdings's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.
Valeritas Holdings (Valeritas Holdings) Business Description
Valeritas Holdings Inc is a commercial-stage medical technology company. It is engaged in the business of improving health and simplifying life for diabetic patients by developing and commercializing innovative technologies. The company designed its first commercialized product, the V-Go Wearable Insulin Delivery Device, or V-Go, that supports the patients with Type 2 diabetes who need insulin to achieve and maintain their target blood glucose goals. V-Go is a small easy-to-use disposable insulin delivery device that a patient wears on his or her skin every 24 hours. It commenced commercial sales of V-Go first in the US and has a sales footprint spread across the country. The company primarily generates its revenues in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VLRXQ has been successfully added to your 